This webinar will be hosted live and available on-demand

Tuesday, March 7, 2023 
1:00 PM Eastern Time 

The gut microbiome contributes to the host immune activation in health and disease. During cancer development and progression, the gut microbiome shows distinct signatures in patients who responded favorably to immune checkpoint inhibitor therapy (ICT). 

In this webinar brought to you by IsoPlexis, Andrew Y. Koh will discuss how scientists used functional proteomics to examine the effect of the gut microbiome on the adaptive immune response, enhancing ICT efficacy in a preclinical melanoma model.

Topics to be Covered 

  • Gut microbiome comparisons during ICT therapy in clinical studies
  • Identifying gut microbiome signatures associated with ICT
  • Modeling cancer gut microbiome in a preclinical model
Nikolai Slavov, PhD

Andrew Y. Koh, MD
Associate Professor, Pediatrics and Microbiology
Harold C. Simmons Comprehensive Cancer Center
Director, Cellular and Immunotherapeutics Program
Children's Medical Center Dallas
University of Texas Southwestern Medical Center

Sponsored by